Kivo Health Closes $10M to Expand Virtual COPD Care
Kivo Health raised $10M Series A led by Allumia Ventures to expand AI-powered virtual care for seniors with chronic lung disease.
The big picture: Kivo Health, a healthcare technology company providing AI-powered virtual care for seniors with chronic lung disease, has closed an oversubscribed $10 million Series A financing round led by Allumia Ventures, bringing its total funding to more than $16 million.
Why it matters:
- Addressing a critical gap: Despite being an established treatment for COPD, pulmonary rehabilitation sees limited participation, with a large Medicare study finding only 2.7% of hospitalized patients receiving it within 12 months.
- Improving access: Kivo Health’s virtual model removes significant barriers like mobility challenges, transportation, and limited access to specialized facilities, making rehabilitation and ongoing disease management available in patients’ homes.
- Reducing healthcare costs: An independent actuarial analysis estimated Kivo’s care model could reduce total healthcare spending by approximately $8,245 per member annually by lowering hospitalizations and emergency department visits.
How it works:
- AI-enabled platform: Kivo Health combines dedicated clinical teams with an AI-enabled care platform designed to monitor patients, support treatment adherence, and facilitate earlier intervention when symptoms worsen.
- Virtual pulmonary rehabilitation: The company’s flagship offering is a fully virtual pulmonary rehabilitation program, allowing patients to participate in supervised treatment without needing to travel to a healthcare facility.
- Continuous clinical support: The approach provides consistent clinical engagement between physician appointments, aiming to reduce avoidable hospitalizations and emergency department visits through proactive disease management.
The catch: While Kivo Health’s virtual model shows promising results in patient engagement and cost reduction, scaling its partnerships with health plans and government programs nationwide will be critical. The chronic disease management market is competitive, and sustained clinical and financial outcomes across diverse patient populations will be key to long-term success.
Key Facts
- Company: Kivo Health
- Amount: $10M
- Round: Series A
- Investors: Allumia Ventures (lead), Corewell Health Ventures, Y Combinator, Heuristic Capital, MassMutual Ventures
- Founder: Victor Sadauskas
- Sector: Virtual Care for Chronic Lung Disease
AIPressRoom Weekly
Every round we reported this week, the people behind the companies, and the events coming up. One email, every Tuesday.